Answer: e, iproniazid
It was not until the introduction of the first MAOI—iproniazid—that the term “atypical depression” began to emerge to describe a particular variant of nonendogenous depression. For more on this topic, see "Atypical Depression in the 21st Century: Diagnostic and Treatment Issues," by Mario A. Cristancho, MD, John P. O’Reardon, MD, and Michael E. Thase, MD, from which this quiz was adapted.
